natgillin/translations-raw huggingface dataset:
Dosages of these drugs may require adjustment in view of the fact that their effects may be modified by changes in cellular electrolyte concentrations. 
Odmerke teh zdravil bomo morda morali prilagoditi, ker na njihove učinke lahko vplivajo spremembe v koncentracijah celičnih elektrolitov.
Salmon calcitonin is devoid of embryotoxic, teratogenic and mutagenic potential. 
Lososov kalcitonin nima potencialno embriotoksičnih, teratogenih in mutagenih učinkov.
Such allergic reactions have only been seen in a very few cases and the most extreme form, anaphylactic shock, is very rare. 
Takšne alergijske reakcije so se pojavile samo v nekaterih primerih, najekstremnejša oblika, anafilaktični šok, pa je izredno redka.
If you have the impression that the effect of FORCALTONIN is too strong or too weak, talk to your doctor or pharmacist. 
Če menite, da je učinek FORCALTONINa premočan ali prešibak, se o tem pogovorite s svojim zdravnikom ali farmacevtom.
Rare: Neutralising antibodies to calcitonin rarely develop. 
Redki: nevtralizirajoča protitelesa za kalcitonin se razvijejo le redko.
If you forget to take FORCALTONIN: 
Če ste pozabili vzeti FORCALTONIN:
For subcutaneous, intramuscular or intravenous infusion (product specific) use in individuals aged 18 years or more. 
Za subkutano in intramuskularno uporabo ali intravensko infuzijo (specifično za zdravilo) pri osebah, starejših od 18 let.
In some cases, however, your doctor may decide to use another dose or another frequency of dosing. 
Zdravnik se v nekaterih primerih lahko odloči za drugačen odmerek ali drugačno razporeditev odmerkov.
Calcitonin should be used during pregnancy only under exceptional circumstances appreciated by the physician. 
Kalcitonin se sme uporabljati med nosečnostjo le v posebnih okoliščinah, ki jih ugotovi zdravnik.
If you use more FORCALTONIN than you should: 
Če ste vzeli večji odmerek FORCALTONINa, kot bi smeli:
It is recommended to store the ampoule in the lower part or the door of the refrigerator to protect the solution from freezing. 
Priporočamo, da ampule shranjujete v spodnjem delu ali predalu na vratih hladilnika, da raztopina ne zamrzne.
Any product where such defects are observed should be discarded. 
Zdravilo, kjer opazite takšne napake, je treba zavreči.
Prevention of bone loss due to sudden immobilisation. 
Preprečevanje izgubljanja kostnine zaradi nenadne nepokretnosti.
Forcaltonin should be used immediately after the single-use ampoule is opened. 
Forcaltonin morate uporabiti takoj, ko je ampula za enkratno uporabo odprta.
Calcitonin is also contraindicated in patients with hypocalcaemia. 
Kalcitonin je kontraindiciran tudi pri bolnikih s hipokalciemijo.
Should symptoms of overdose appear, treatment should be symptomatic. 
Če se pojavijo simptomi prevelikega odmerjanja, jih zdravimo simptomatsko.
Rare: In case of patients with high bone remodelling (Paget's disease and young patients) a transient decrease of calcaemia may occur between the 4th and the 6th hour after administration, usually asymptomatic 
Redki: pri bolnikih z visoko stopnjo preoblikovanja kostnine (Pagetova bolezen in mladi bolniki) se lahko pojavi prehodno zmanjšanje kalciemije med 4. in 6. uro po danem zdravilu, ponavadi asimptomatsko.
Do not use FORCALTONIN: if you are hypersensitive (allergic) to salmon calcitonin or any of the other ingredients of FORCALTONIN. 
Ne uporabljajte zdravila FORCALTONIN: - Če ste preobčutljivi za (alergični na) lososov kalcitonin ali katerokoli sestavino zdravila FORCALCITONIN.
Nausea/vomiting are less frequent when the injection is done in the evening and after meals. 
Slabost in bruhanje sta manj pogosta, če zdravilo injiciramo zvečer in po zaužitem obroku.
The salmon calcitonin contained in Forcaltonin is not made by a conventional, chemical method but by genetic engineering. 
Lososov kalcitonin v zdravilu Forcaltonin ni izdelan na klasičen kemijski način, temveč z genskim inženirstvom.
The length of time over which you will receive FORCALTONIN will depend on the way you respond to the treatment. 
Koliko časa boste prejemali FORCALTONIN, je odvisno od tega, kako se odzivate na zdravljenje.
Store in a refrigerator (2°C - 8°C) . 
Shranjujte v hladilniku (2ºC - 8°C).
Like all medicines, FORCALTONIN may have undesirable effects which are very rare. 
Kot vsa zdravila ima lahko tudi FORCALTONIN neželene učinke, ki so zelo redki.
If the response to treatment is not satisfactory after one or two days, the dose may be increased to 400 International Units every 6 to 8 hours. 
Če odziv na zdravljenje po enem do dveh dnevih ni zadovoljiv, se odmerek lahko poveča na 400 mednarodnih enot na vsakih 6 do 8 ur.
An antiemetic may be administered, if required. 
Bolniku lahko po potrebi damo antiemetik.
6.6 Instructions for use and handling <and disposal> For subcutaneous, intramuscular or intravenous use. 
6.6 Navodila za pripravo in ravnanje z zdravilom <in odlaganje> Za subkutano, intramuskularno ali intravensko dajanje.
BATCH NUMBER <Batch> <Lot> <BN> {number} 
ŠTEVILKA SERIJE <Serija> <Lot> <BN> {številka}
Serious allergic reactions will need emergency treatment. 
Hude alergijske reakcije je treba takoj zdraviti.
Extreme sensitivity to salmon calcitonin may cause difficulties in breathing (bronchospasm), swelling of the tongue or throat, or even an anaphylactic shock (a very severe type of allergic response). 
Pretirana občutljivost na lososov kalcitonin lahko povzroči težave z dihanjem (bronhospazem), otekanje jezika ali grla ali celo anafilaktični šok (ki je zelo hud tip alergijske reakcije).
Salmon calcitonin is primarily and almost exclusively degraded in the kidneys, forming pharmacologically inactive fragments of the molecule. 
Lososov kalcitonin se primarno in skoraj izključno razgrajuje v ledvicah, kjer se tvorijo farmakološko neaktivni delci molekule.
Pharmacotherapeutic group: antiparathyroid hormone, ATC code: H05BA01 (calcitonin, salmon). 
Farmakoterapevtska skupina: paratiroideo zavirajoči hormoni, oznaka ATC: H05BA01 (lososov kalcitonin).
If the response is not satisfactory after one or two days, the dose may be increased to a maximum of 400 IU every 6 to 8 hours. 
Če odziv po enem ali dveh dnevih ni zadovoljiv, lahko odmerek povečamo na največ 400 IE vsakih 6 do 8 ur.
However, FORCALTONIN might influence the effects of certain drugs given to treat heart complaints. 
Vendar pa FORCALTONIN lahko vpliva na učinkovanje nekaterih zdravil za zdravljenje težav s srcem.
Examples of serious allergic reactions to salmon calcitonin are: 
Znaki resne alergijske reakcije na lososov kalcitonin so:
It is contained in a glass ampoule. 
Na voljo je v stekleni ampuli.
Calcitonin has short absorption and elimination half-lives of 10-15 minutes and 50-80 minutes, respectively. 
Kalcitonin ima kratek absorpcijski čas od 10 do 15 minut in razpolovni čas izločanja od 50 do 80 minut.
Approximately 10% of patients treated with salmon calcitonin suffer from nausea, sometimes with vomiting. 
Približno 10 % bolnikov, zdravljenih z lososovim kalcitoninom, muči občutek slabosti, ki ga včasih spremlja bruhanje.
The manufacturer is FAMAR S.A., 7 P. Marinopoulou Str., 174 56 Alimos, Athens, Greece. 
Izdelovalec je FAMAR S.A., 7 P. Marinopoulou Str., 174 56 Alimos, Atene, Grčija.
Calcitonin is secreted into the milk. 
Kalcitonin se izloča v mleko.
HOW TO USE FORCALTONIN 
KAKO UPORABLJATI FORCALTONIN
FORCALTONIN is only available from your doctor. 
FORCALTONIN vam lahko predpiše le zdravnik.
The use of calcitonin in combination with bisphosphonates may result in an additive calcium-lowering effect. 
Uporaba kalcitonina v kombinaciji z bifosfonati ima lahko za posledico aditiven učinek na zmanjševanja kalcija.
The effect disappears without the need for special treatment. 
Učinek je izginil, ne da bi ga bilo treba posebej zdraviti.
The development of these antibodies is not usually related to loss of clinical efficacy, although their presence in a small percentage of patients following long-term therapy with calcitonin may result in a reduced response to the product. 
Njihov nastanek ponavadi ni povezan z zmanjšanjem klinične učinkovitosti, čeprav njihova prisotnost pri majhnem odstotku bolnikov po daljšem zdravljenju s kalcitoninom lahko zmanjša odziv na zdravilo.
By inhibiting osteoclast activity via its specific receptors, salmon calcitonin decreases bone resorption. 
Z zaviranjem delovanja osteoklastov prek svojih specifičnih receptorjev lososov kalcitonin zmanjšuje resorpcijo kosti.
Should the solution become frozen, the ampoule must be discarded. 
Če raztopina zamrzne, morate ampulo zavreči.
In addition, salmon calcitonin could be administered by intravenous injection after previous rehydration. 
Lososov kalcitonin lahko dajemo tudi z intravenskim injiciranjem po predhodni rehidraciji.
• Prevention of acute bone loss due to sudden immobilisation such as in patients with recent osteoporotic fractures 
• za preprečevanje akutnega izgubljanja kostnine zaradi nenadne nepokretnosti, na primer pri bolnikih z nedavnim osteoporoznim zlomom;
The solution is clear, colourless and sterile. 
Raztopina je prozorna, brezbarvna in sterilna.
Your doctor may then decide that it is not safe for you to receive this medicine. 
Vaš zdravnik potem lahko odloči, ali je jemanje tega zdravila za vas varno - če imate hipokalciemijo
If you or your doctor accidentally inject more than the recommended dose of FORCALTONIN, it is extremely unlikely to have any serious effects. 
Če si nehote injicirate večji odmerek FORCALTONINa od priporočenega ali če vam ga nehote injicira zdravnik, je zelo malo verjetno, da bi to lahko imelo kakršnokoli resno posledico.
It is also used to treat Paget's disease (a chronic disease of the bones characterised by inflammation and deformation), and hypercalcaemia of malignancy (increased calcium blood levels due to tumours). 
Uporabljamo ga tudi za zdravljenje Pagetove bolezni (kronične bolezni kosti, za katero sta značilna vnetje in deformiranje kosti) in hiperkalciemije zaradi malignih obolenj (povečane ravni kalcija v krvi zaradi tumorjev).
Nervous system disorders: Uncommon: metallic taste in the mouth; dizziness 
Bolezni živčevja Občasni: kovinski okus v ustih; omotičnost
The effect of calcitonin may be monitored by measurement of suitable markers of bone remodeling, such as serum alkaline phosphatase or urinary hydroxyproline or deoxypyridinoline. 
Učinek kalcitonina lahko spremljamo z merjenjem ustreznih markerjev preoblikovanja kosti, npr. serumske alkalne fosfataze ali hidroksiprolina ali dezoksipiridinolina v urinu.
Paget's disease of bone. 
Pagetova bolezen kosti.
There is a relationship between the subcutaneous dose of calcitonin and peak plasma concentrations. 
Obstaja povezava med subkutanim odmerkom kalcitonina in maksimalnimi koncentracijami v plazmi.
However, care should be exercised in patients receiving concurrent treatment with cardiac glycosides or calcium channel blocking agents. 
Vseeno pa moramo biti previdni pri bolnikih, ki hkrati prejemajo tudi srčne glikozide ali blokatorje kalcijevih kanalčkov.
Prevention of acute bone loss: 
Preprečevanje akutnega izgubljanja kostnine
It is not known if the substance is excreted in human milk. 
Ni znano, ali se učinkovina izloča v materino mleko.
Very common: Nausea with or without vomiting is noted in approximately 10% of patients treated with calcitonin. 
Zelo pogosti: slabost, ki jo lahko spremlja bruhanje, so opazili pri približno 10 % bolnikov, zdravljenih s kalcitoninom.
Patients must therefore be warned that transient dizziness may occur, in which case they should not drive or use machines. 
Bolnike moramo zato opozoriti, da se lahko pojavi prehodna omotičnost in da v tem primeru ne smejo voziti ali upravljati strojev.
In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal products. 
Zdravilo se ne sme mešati z drugimi zdravili, ker ni na voljo študij o kompatibilnosti.
Calcitonin should be used during pregnancy only if treatment is considered absolutely essential by the physician. 
Med nosečnostjo naj se kalcitonin uporablja le, če zdravnik meni, da je terapija nujno potrebna.
The recommended dosage is 100 IU per day administered subcutaneously or intramuscularly, however, a minimum dosage regimen of 50 IU three times a week has achieved clinical and biochemical improvement. 
Priporočeni odmerek je 100 IE na dan subkutano ali intramuskularno, vendar lahko z minimalnimi odmerki 50 IE trikrat na teden dosežemo klinično in biokemično izboljšanje.
General disorders and administration site conditions Uncommon: local inflammatory reactions at the site of subcutaneous or intramuscular injection 
Splošne težave in spremembe na mestu aplikacije Občasni: lokalne vnetne reakcije na mestu subkutanega ali intramuskularnega injiciranja
No data exist on the effects of injectable calcitonin on the ability to drive and use machines. 
O vplivu kalcitonina za injiciranje na sposobnost vožnje in upravljanja strojev ni podatkov.
MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE 
IZDELOVALEC BIOLOŠKE ZDRAVILNE UČINKOVINE IN IMETNIK DOVOLJENJA ZA IZDELAVO ZDRAVILA, ODGOVOREN ZA SPROŠČANJE SERIJE
Very rare: serious allergic-type reactions, such as bronchospasm, swelling of the tongue and throat, and in isolated cases, anaphylaxis. 
Zelo redki: hude reakcije alergijskega tipa, kot so bronhospazem, zatekanje jezika in grla ter v nekaterih primerih anafilaksa.
Because calcitonin is a peptide, the possibility of systemic allergic reactions exists and allergic-type reactions including isolated cases of anaphylactic shock have been reported in patients receiving calcitonin. 
Ker je kalcitonin peptid, obstaja možnost sistemskih alergijskih reakcij; poročali so o reakcijah alergijskega tipa pri bolnikih, ki so prejemali kalcitonin, s posameznimi primeri anafilaktičnega šoka.
Salmon calcitonin is a hormone which increases the amount of calcium and phosphate laid down in the bones and lowers the level of calcium circulating in the blood. 
Lososov kalcitonin je hormon, ki zvišuje količino kalcija in fosfata v kosteh in znižuje raven kalcija v krvi.
Calcitonin receptor down-regulation may also result in a reduced clinical response in a small percentage of patients following long-term therapy. 
Tudi zmanjševanje števila receptorjev za kalcitonin na tarčni celici (»down-regulation«) lahko pri majhnem odstotku bolnikov po dolgoročnem zdravljenju povzroči zmanjšan klinični odziv.
FORCALTONIN is used to prevent loss of bone if you are suddenly immobilised, for example, after having a fracture due to osteoporosis. 
FORCALTONIN preprečuje izgubljanje kostnine, če postanete nepričakovano nepokretni, na primer po zlomu zaradi osteoporoze.
Frequency categories: 
Navedba pogostnosti:
Nausea, vomiting, flushing and dizziness are known to be dose dependent when calcitonin is administered parenterally. 
Znano je, da so slabost, bruhanje in omotičnost odvisni od odmerka pri parenteralnem dajanju kalcitonina.
Storing FORCALTONIN 
SHRANJEVANJE FORCALTONINA
The recommended starting dose is 100 IU every 6 to 8 hours by subcutaneous or intramuscular injection. 
Priporočeni začetni odmerek je 100 IE na vsakih 6 do 8 ur s subkutanim ali intramuskularnim injiciranjem.
If you have any questions about the length of your treatment, ask your doctor or nurse. 
Če imate vprašanja o trajanju zdravljenja, vprašajte svojega zdravnika ali medicinsko sestro.
Use of FORCALTONIN in children: It is not recommended to use FORCALTONIN in children. 
Uporaba FORCALTONINA pri otrocih: Uporabo FORCALTONINA pri otrocih odsvetujemo.
Please tell your doctor if you are receiving treatment for a heart complaint, because the dose of the heart drug may need to be adjusted. 
Če vas zdravijo zaradi težav s srcem, seznanite s tem svojega zdravnika, ker bo treba morda ustrezno spremeniti odmerek vašega zdravila za srce.
In lactating animals given calcitonin, suppression of milk production has been observed. 
Pri doječih živalih, ki so prejemale kalcitonin, se je bilo zmanjšalo nastajanje mleka.
Uncommon: diarrhea 
Občasni: diareja
MANUFACTURER'S BATCH NUMBER <Batch> <Lot> <BN>{number} 
IZDELOVALČEVA ŠTEVILKA SERIJE IZDELAVE ZDRAVILA <Serija> <Lot> <BN> {številka}
Decreases in bone resorption as judged by a reduction in urinary hydroxyproline and deoxypyridinoline are observed following calcitonin treatment in both normal volunteers and patients with bone-related disorders, including Paget's disease and osteoporosis. 
Zmanjšano resorpcijo kosti, ocenjeno na podlagi zmanjšanja hidroksiprolina in dezoksipiridinolina v urinu, so opazili po zdravljenju s kalcitoninom tako pri zdravih prostovoljcih kot pri bolnikih z boleznimi kosti, vključno s Pagetovo boleznijo in osteoporozo.
Salmon calcitonin may be administered at bedtime to reduce the incidence of nausea or vomiting which may occur, especially at the initiation of therapy. 
Lososov kalcitonin lahko dajemo pred spanjem, da zmanjšamo pogostnost slabosti ali bruhanja, ki se lahko pojavi, zlasti na začetku zdravljenja.
You should tell your doctor if you are taking other calcium lowering drugs, such as bisphosphonates, as the combination of these drugs with FORCALTONIN might cause the amount of calcium in your blood to become too low. 
Če jemljete druga zdravila za zniževanje kalcija, na primer biofosfonate, povejte svojemu zdravniku; jemanje teh zdravil skupaj s FORCALTONINom lahko povzroči, da se preveč zniža količina kalcija v krvi.
Patients must therefore be warned that transient dizziness may occur, in which case they should not drive or use machines.” 
Bolnike moramo zato opozoriti, da se lahko pojavi prehodna omotičnost in da v tem primeru ne smejo voziti ali upravljati strojev
Calcitonin markedly reduces bone turnover in conditions with an increased rate of bone resorption such as Paget ‘s disease and acute bone loss due to sudden immobilisation. 
Kalcitonin opazno zmanjšuje kostno presnovo pri bolezenskih stanjih s povečano hitrostjo resorpcije kosti, na primer pri Pagetovi bolezni in akutnem izgubljanju kostnine zaradi nenadne nepokretnosti.
Animal studies have shown that calcitonin is primarily metabolised via proteolysis in the kidney following parenteral administration. 
Študije na živalih so pokazale, da se kalcitonin po parenteralnem dajanju primarno presnavlja s proteolizo v ledvicah.
This undesirable effect occurs mostly at the beginning of treatment and tends to decrease or even disappear as treatment continues. 
Ta neželeni učinek se navadno pojavi na začetku zdravljenja, z nadaljevanjem zdravljenja pa običajno izgine ali se zmanjša.
QUALITATIVE AND QUANTITATIVE COMPOSITION One ampoule of Forcaltonin 100 IU contains 100 International Units (IU) corresponding to approximately 15 micrograms recombinant salmon calcitonin (produced by recombinant DNA technology in Escherichia coli) in 1 ml of an acetate buffer. 
KAKOVOSTNA IN KOLIČINSKA SESTAVA Ena ampula Forcaltonina 100 IE vsebuje 100 mednarodnih enot (IE), kar ustreza približno 15 mikrogramom rekombinantnega lososovega kalcitonina (proizveden z rekombinantno DNK tehnologijo v Escherichia coli) v 1 ml acetatnega pufra.
However, the structure of the active substance of FORCALTONIN is the same as that of chemically synthesised salmon calcitonin. 
Vendar pa je struktura zdravilne učinkovine v FORCALTONINu enaka kot pri kemijsko sintetiziranem lososovem kalcitoninu.
Therefore, the metabolic clearance is much lower in patients with end-stage renal failure than in healthy subjects. 
Zato je presnovni očistek mnogo nižji pri pacientih s končno odpovedjo ledvic kot pri zdravih osebah.
There have been no reports that other drugs influence the effects of FORCALTONIN. 
Vpliv drugih zdravil na učinek FORCALTONINa ni znan.
calcitonin, peak plasma concentration lies between about 200 and 400 pg/ml. 
Po parenteralnem dajanju 100 IE kalcitonina je maksimalna koncentracija v plazmi med 200 in 400 pg/ml.
Do not use after the expiry date stated on the ampoule and the packaging. 
Zdravila ne smete uporabljati po izteku roka uporabnosti, ki je naveden na ampuli in na škatli.
174 56 Alimos, Athens, Greece. 
7, P. Marinopoulou Str. 174 56 Alimos, Atene, Grčija
OTHER SPECIAL WARNING(S), IF NECESSARY 
DRUGA POSEBNA OPOZORILA, ČE SO POTREBNA NE ZAMRZUJTE.
Important Information about some of the Ingredients of FORCALTONIN This medicinal product contains less than 1 mmole (23 mg) sodium per dose, i.e. essentially sodium free. 
Pomembni podatki o nekaterih sestavinah FORCALTONINA To zdravilo vsebuje manj kot 1 mmol (23 mg) soli na dozo, t.j.
The effects of recombinant salmon calcitonin on the body have also been shown to be equivalent to those of synthetic salmon calcitonin. 
Pokazalo se je, da so učinki rekombinantnega lososovega kalcitonina na telo enakovredni učinkom sintetično pridobljenega lososovega kalcitonina.
A minimum dose of 50 International Units (7.5 micrograms of salmon calcitonin) three times a week in some patients may be sufficient. 
Pri nekaterih bolnikih lahko zadošča najnižji odmerek 50 mednarodnih enot (7,5 mikrograma lososovega kalcitonina) trikrat na teden.
Unigene UK Limited 191 Sparrows Herne Bushey Heath Hertfordshire WD23 1AJ United Kingdom 
Unigene UK Limited 191 Sparrows Herne Bushey Heath Hertfordshire WD23 1AJ Velika Britanija
Skin testing should be conducted in patients with suspected sensitivity to calcitonin prior to their treatment with calcitonin. 
Pri bolnikih, za katere sumimo, da so občutljivi na kalcitonin, je treba pred začetkom uporabe zdravila opraviti kožno testiranje.
Salmon calcitonin does not cross the placental barrier. 
Lososov kalcitonin ne prehaja skozi placento.
Keep out of the reach and sight of children 
Zdravilo shranjujte zunaj dosega in pogleda otrok.
MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS {NATURE/TYPE} 
PODATKI, KI MORAJO BITI NAVEDENI NA MANJŠIH STIČNIH OVOJNINAH {VRSTA/TIP}
The following instructions for use are recommended to ensure that you obtain the full benefit of treatment with FORCALTONIN. 
Priporočamo vam, da upoštevate to navodilo za uporabo, da vam bo FORCALTONIN kar najbolj koristil.
The calcium-lowering effect of calcitonin is caused both by a decrease in the efflux of calcium from the bone to the ECF and inhibition of renal tubular reabsorption of calcium. 
Kalcitoninov učinek na zniževanje kalcija povzročata zmanjšano prehajanje kalcija iz kosti v ECT in tudi inhibicija ledvične tubulne reabsorpcije kalcija.
Forcaltonin is contained in Type I, glass ampoules, designed to accommodate up to 1 ml of solution. 
Forcaltonin je na voljo v steklenih ampulah iz stekla vrste I oblike B, ki vsebujejo do 1 ml raztopine.
Calcitonin is a calciotropic hormone, which inhibits bone resorption by a direct action on osteoclasts. 
Kalcitonin je kalciotropen hormon, ki zavira resorpcijo kosti z neposrednim delovanjem na osteoklaste.
Do not use Forcaltonin if you notice the solution is not completely clear and colourless. 
Forcaltonina ne smete uporabiti, če raztopina ni prozorna in brezbarvna.
The effect is more evident on initiation of therapy and tends to decrease or disappear with continued administration or a reduction in dose. 
Ta učinek je bolj viden na začetku in se ponavadi zmanjša ali izgine med nadaljevanjem zdravljenja ali z zmanjšanjem odmerka.
Skin and subcutaneous tissue disorders Uncommon: skin rash 
Bolezni kože in podkožja Občasni: kožni izpuščaj
• Paget's disease 
Pagetova bolezen
In animals, salmon calcitonin has been shown to decrease lactation and to be excreted in milk (see 5.3). 
Pri živalih se je pokazalo, da lososov kalcitonin zmanjšuje laktacijo in prehaja v materino mleko (glejte poglavje 5.3), zato dojenje med zdravljenjem odsvetujemo.
The absence of mineralisation defect with calcitonin has been demonstrated by bone histomorphometric studies both in man and in animals. 
S histomorfometričnimi študijami so dokazali odsotnost napak v mineralizaciji tako pri ljudeh kot pri živalih.
FORCALTONIN is a solution for injection. 
FORCALTONIN je raztopina za injiciranje.
In pharmacological studies, calcitonin has been shown to have analgesic activity in animal models. 
Farmakološke študije so pokazale, da je imel kalcitonin na živalskih modelih protibolečinski učinek.
Metabolic and nutrition disorders: 
Presnovne in prehranske motnje
• diarrhoea 
• diareja,